Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report report published on Monday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

AMPE opened at $0.00 on Monday. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $7.47. The stock has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 3.67.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.